BHVN - Biohaven Ltd
Close
39.4
-0.410 -1.041%
Share volume: 853,091
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$39.81
-0.41
-1.03%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | |
|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | |
| Report Date | 2022-05-10 | 2022-08-05 | |
| Assets | |||
| Total Assets | 1.372 B | 1.386 B | |
| Current Assets | 1.171 B | 1.174 B | |
| Inventories | 91.281 M | 106.561 M | |
| Other Current Assets | 148.987 M | 161.845 M | |
| Short Term Investments | 148.987 M | 161.845 M | |
| Total Receivables | 328.342 M | 352.449 M | |
| Current Cash | 602.475 M | 553.486 M | |
| Total Non-current Assets | 200.632 M | 211.908 M | |
| Property Plant Equipment | 14.534 M | 15.727 M | |
| Other Assets | 130.188 M | 121.069 M | |
| Intangible Assets | 55.910 M | 75.112 M | |
| Goodwill | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||
| Total Liabilities and shareholders’ equity | 1.372 B | 1.386 B | |
| Total liabilities | 1.834 B | 2.187 B | |
| Total current liabilities | 576.114 M | 671.956 M | |
| Accounts Payable | 56.202 M | 64.149 M | |
| Other liabilities | 464.916 M | 574.655 M | |
| Current long term debt | 62.500 M | 62.500 M | |
| Long term debt | 797.100 M | 945.196 M | |
| Other liabilities | 464.916 M | 574.655 M | |
| Minority interest | -4.127 M | -4.625 M | |
| Total Shareholder equity | -462.286 M | -800.933 M | |
| Common stock | 70.332 M | 71.044 M | |
| Retained earnings | -2.702 B | -3.144 B |